Salarius Pharmaceuticals files $2.6M ATM equity offering via Ladenburg Thalmann

Decoy Therapeutics Inc.

Offering of up to $2.6M of common stock at-the-market under existing S-3 shelf registration.
Sales agent is Ladenburg Thalmann & Co. Inc.; prospectus supplement dated August 22, 2025.
Shares have $0.0001 par value; legal opinion of Hogan Lovells included as Exhibit 5.1.
Proceeds intended for general corporate purposes; no specific use stated.

item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.